• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2001 Fiscal Year Final Research Report Summary

Molecular design of functional domain-mimics of receptors and ligands

Research Project

Project/Area Number 11490029
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field 広領域
Research InstitutionKagoshima University

Principal Investigator

SUGIMURA Kazuhisa  Kagoshima University, Faculty of Engineering, Professor, 工学部, 教授 (80127240)

Co-Investigator(Kenkyū-buntansha) HASHIGUCHI Shuhei  Kagoshima University, Faculty of Engineering, Research Associate, 工学部, 助手 (40295275)
BABA Masanori  Kagoshima University, Faculty of Medicine, Professor, 医学部, 教授 (70181039)
ITO Yuji  Kagoshima University, Faculty of Engineering, Associate Professor, 工学部, 助教授 (60223195)
Project Period (FY) 1999 – 2001
KeywordsPhage library / Peptide mimic / scFv / Human antibody / MCP-1 / IL-6 / Inhibitor / Molecular design
Research Abstract

We tested the approach to design the peptide mimics of the receptor/ligand-binding domain by panning a phage display library using their conformational epitope-recognizing monoclonal antibodies. We demonstrated the feasibility of this approach by the reports of Nature biotechnology (16 : 267-270, 1998) and J. Immunol. (161 : 6622-6628).
In this study, we attempted to design the mimic molecule of MCP-1 (monocyte chemoattractant protein-1) and IL-6. In the case of MCP-1, we successfully identified the MCP-1 peptide mimic motifs of 19 amino acids, named G25 and C27. Both motifs contain two cysteins in their sequences. The synthetic and intramolecularly disulfide-linked peptides of these motifs inhibited the chemotaxis induced by MCP-1, while their derivatives with serine in place of cysteine did not.
In the case of IL-6, we identified the #37 motif which specifically bound to human IL-6. The synthetic 13 amino acid peptide of #37 motif inhibited the proliferation of human KT-3 cell lines induced with the stimulation of IL-6. On the other hand, The #37 peptide showed no inhibition on the proliferation of murine MH60 which is the IL-6-dependent cell line.
Thus, the G25, C27 and #37 peptide may be the leading peptides with antagonistic activities and useful for the therapy of inflammatory and autoimmune diseases such as rheumatoid arthritis.

  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] M.Kaji, M.Ikari, S.Hashiguchi, Y.Ito, R.Matsumoto, T.Yoshimura, J.Kuratsu, K.Sugimura: "Peptide Mimics of Monocyte Chemoattractant Protein-1 (MCP-1) with an Antagonistic Activity"J. Biochem, 129 577-583, 2001. 129. 577-583 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M.Kawamura T.Naito, M.Ueno, T.Akagi, K.Hiraishi, I.Takai, M.Makino, T.Serizawa, K.Sugimura, M.Akashi, M.Baba: "Induction of mucosal IgA following intravaginal administration of inactivated HIV-1-capturing nanospheres in mice"J. Med. Virol.. 66. 291-298 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 杉村 和久, 吉満 正明, 御手洗 睦和. 新村 靖彦: "HIV-1エントリーインヒビター"臨床免疫. 35.5. 594-694 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 橋口 周平, 杉村 和久: "皮膚に塗るDNAワクチン"臨床免疫. 36.6. 949-952 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] K.Sugimura, R.Gejima, T.Nakashima, S.Hashiguchi, Y.Ito, S.Okuhata, N.Nishimoto, K.Yoshizaki: "Anti-IL6 antibody-binding motif peptides inhibiting the signaling of human IL-6 to human IL-6 receptor but not murine IL-6 receptor"Scandinavian Journal of Immunology. 54. 105 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hashiguchi S, Nitani A, Nakashima T, Ito Y, Sugimura K.: "Human FceRI-specific human single chain Fv (scFv) antibody"Scandinavian Journal of Immunology. 54. 103 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M. Kaji, M. Ikari, S. Hashiguchi, Y. Ito, R. Matsumoto, T. Yoshimura, J. Kuratsu, and K. Sugimura: "Peptide Mimics of Monocyte Chemoattractant Protein-1 (MCP-1) with an Antagonistic Activity"J. Biochem.. 129. 577-583 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M. Kawamura, T. Naito, M. Ueno, T. Akagi, K. Hiraishi, I. Takai, M. Makino, T. Serizawa, K. Sugimura, M. Akashi, M. Baba: "Induction of mucosal IgA following intravaginal administration of inactivated HIV-1-capturing nanospheres in mice"J. Med. Virol.. 66. 291-298 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] K. Sugimura, M. Yoshimitsu, M. Mitarai, Y. shinmura: "HIV-1 intry inhibitor"Clin. Immunol.. 35 (5). 594-604 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] S. Hashigichi, K. Sugimura: "DNA vaccine by skin immunization"Clin. Immunol.. 36 (6). 949-952 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] K. Sugimura, R. Gejima, T. Nakashima, S. Hashiguchi, Y. Ito, S. Okuhata, N. Nishimoto, K. Yoshizaki: "Anti-IL-6 antibody-binding motif peptides inhibiting the signaling of human IL-6 to human IL-6 receptor but not murine IL-6 receptor"Scandinavian Journal of Immunology. 54. 105 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] D. Hashiguchi, A. Nitani, T. Nakashima, Y. Ito, K. Sugimura: "Human FceRI-specific human single chain Fv (scFv) antibody"Scandinavian Journal of Immunology. 54. 103 (2001)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2003-09-17  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi